方法对67例失代偿肝硬化并发肺部感染患者的临床资料进行了回顾性分析。
Methods a retrospective analysis was made in 67 cases with decompensated cirrhosis suffered from the pulmonary infection.
《国际肝病》：目前对于阻止失代偿肝硬化进展或逆转肝硬化有哪些药物治疗进展？
Hepatology Digest: What advances in pharmacological treatment can halt progression to decompensated cirrhosis or reverse cirrhosis?
结论结肠灌注透析治疗对失代偿性肝硬化顽固性腹水及内毒素血症、高氨血症、低钠血症均有较好的近期疗效。
Conclusion Colon perfusion dialysis therapy had good short-term effect on the decompensated hepatocirrhosis with intractable ascites, endotoxemia, hyperammonemia and hyponatremia.
目的：探讨在西药综合治疗基础上加用中药“化瘀益气汤”治疗失代偿期肝硬化患者的临床疗效。
Objective:To explore the therapeutic efficacy of Huayu Yiqi Decoction on the basis of western medicine in treatment of decompensatory liver cirrhosis.
目的探讨肝硬化失代偿期老年患者的营养管理方法和效果。
Objective To explore the methods and effect of nutrition management in old patients with liver cirrhosis at decompensation stage.
结论肝硬化失代偿期患者可能存在下丘脑—垂体—性腺轴功能紊乱。
Conclusion There may be dysfunction of hypothalamics-pituitary-gonadal axis system in male patients with cirrhosis decompensation.
失代偿性肝硬化的患病率根据患者的年龄而变化，并且每年增加约2%，但是仅在60岁以上的患者中观察到这一比率的增加更显著。
The prevalence of decompensated cirrhosis varied according to the age of patients and increased by about 2 percent a year, but the increase was seen only in patients over age 60.
结果代偿性肝硬化组服用软肝片后效果明显，失代偿性肝硬化组无明显疗效。
Results the curative effect on the compensatory cirrhosis treated group was significantly better than the decompensated cirrhosis group.
目的：探讨肝硬化失代偿期并发自发性细菌性腹膜炎(SBP)危险因素，提高早期诊断率。
AIM: to investigate the risk factors of decompensated cirrhosis complicated with spontaneous bacterial peritonitis (SBP), and to improve the rate for early diagnosis rate.
方法：随机选择正常肝脏、代偿期和失代偿期肝硬化各100例。
Methods: Normal cases compensated cirrhosis and decompensated cirrhosis each 100 cases respectively were selected at random.
方法对肝硬化代偿期和失代偿期病人的血糖及胰岛素水平进行为期3年的临床监测，并与正常对照组进行对比分析。
Methods The blood sugar and insulin levels in patients with compensatory phase and decompensatory phase cirrhosis were monitored for 3 years and a comparison to the control group has also been done.
目的研究结肠灌注透析对失代偿性肝硬化顽固性腹水及内毒素血症、高氨血症、低钠血症的治疗效果。
Objective to study the curative effect of the colon perfusion dialysis for the decompensated hepatocirrhosis with intractable ascites, endotoxemia, hyperammonemia and hyponatremia.
然而确实存在乳酸酸中毒的一些特征。所以，我只是在肝硬化失代偿患者应用恩替卡韦时认真考虑一下。
However they certainly had some features of the lactic acidosis syndrome and this would make me think twice about using entecavir in patients with decompensated cirrhosis.
目的：探讨肝硬化失代偿期腹水与胆囊壁增厚的临床关系及其诊断价值。
Objective: to investigate the clinical relationship and diagnostic value of ascites and gallbladder wall thickening during hepatocirrhosis decompensation.
目的探讨肝硬化失代偿期合并肝性胸水患者的临床特点。
Objective To investigate the clinical features of decompensate cirrhosis patients with pleural effusion.
健康教育干预对肝硬化失代偿期患者生活质量的影响。
Effect of health educational intervention on life quality of patients with decompensated liver cirrhosis.
目的探讨脉冲组织多普勒(PW - TDI)评价肝硬化失代偿期右心功能的临床价值。
Objective To investigate the value of PW-TDI for estimating right ventricular function in the patients with hepatic cirrhosis.
拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察。
Clinical Observation of Lamivudine for Decompensated Cirrhosis Resulting from Chronic Hepatitis b.
目的：探讨安络化纤丸和还原型谷胱苷肽联合治疗失代偿期肝硬化的临床疗效。
Objective: To investigate the curative effects of An-luo Hua-xian pill and reduced glutathione on decompensated hepatic cirrhosis.
结论饮食干预对肝硬化失代偿期的治疗有重要意义，而且对患者的预后也有重要作用。
Conclusion: dietary interventions for the treatment of decompensated cirrhosis is important period, and the prognosis of the patients with also have an important role.
结论：失代偿性肝硬化患者因纤维蛋白原浓度下降致使纤维蛋白单体聚合功能降低，从而出现低凝状态，这可能是构成出血倾向的原因之一。
Conclusion: Plasma Fbg concentration and fibrin monomer polymerize function were decrease, showed that patients were low coagulation state and contributing to one cause of hemorrhage.
结果肝硬化患者血、尿nag水平明显高于正常对照，失代偿期明显高于代偿期。
Results the results indicated that the NAG levels of patients with liver cirrhosis were higher than those of controls.
方法：对酒精性肝硬化代偿期和失代偿期患者及健康者用放射免疫分析法检测细胞因子的含量进行分析。
Methods: The changes in serum cytokine level in compensated and decompensated alcoholic liver cirrhosis patients and healthy controls were measured by radioimmunoassay technique.
结果：肝硬化失代偿期诱发MOF的主要因素老年组为感染，非老年组为出血，且老年组mOF的发生率、发生衰竭脏器的数目、病死率均高于非老年组。
Results: Infection is a primary factor induced MOF in the group A. But hemorrhage is a primary factor in the group b; there were higher occurrence of MOF and higher morbidity.
住院的患者，绝大部分都是有肝硬化、肝癌和肝功能失代偿比较重的病人。
Hospital patients, the majority is liver cirrhosis, liver cancer and liver decompensation heavier patients.
住院的患者，绝大部分都是有肝硬化、肝癌和肝功能失代偿比较重的病人。
Hospital patients, the majority is liver cirrhosis, liver cancer and liver decompensation heavier patients.
应用推荐